Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-020033
Filing Date
2025-03-04
Accepted
2025-03-04 08:51:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm258141-1_424b5.htm 424B5 549022
2 GRAPHIC lg_bioxcelthera-4c.jpg GRAPHIC 37756
  Complete submission text file 0001104659-25-020033.txt   602172
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275261 | Film No.: 25701723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)